Ident. | Authors (with country if any) | Title |
---|
000F39 (2012) |
Katrina L. Paumier [États-Unis] ; Andrew D. Siderowf [États-Unis] ; Peggy Auinger [États-Unis] ; David Oakes [États-Unis] ; Lalitha Madhavan [États-Unis] ; Alberto J. Espay [États-Unis] ; Fredy J. Revilla [États-Unis] ; Timothy J. Collier [États-Unis] | Tricyclic Antidepressants Delay the Need for Dopaminergic Therapy in Early Parkinson's Disease |
000F43 (2012) |
TAO XIE [États-Unis] ; Robert Goodman [États-Unis] ; Nina Browner [États-Unis] ; Elizabeth Haberfeld [États-Unis] ; Linda Winfield [États-Unis] ; Jill Goldman [États-Unis] ; Blair Ford [États-Unis] | Treatment of Fragile X-Associated Tremor/Ataxia Syndrome with Unilateral Deep Brain Stimulation |
000F68 (2012) |
Diego Garcia-Borreguero [Espagne] ; Birgit Högl [Autriche] ; Luigi Ferini-Strambi [Italie] ; John Winkelman [États-Unis] ; Christina Hill-Zabala [États-Unis] ; Afsaneh Asgharian [États-Unis] ; Richard Allen [États-Unis] | Systematic Evaluation of Augmentation during Treatment with Ropinirole in Restless Legs Syndrome (Willis-Ekbom Disease): Results from a Prospective, Multicenter Study over 66 Weeks |
000F69 (2012) |
Susanne A. Schneider [Allemagne, Royaume-Uni] ; John Hardy [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] | Syndromes of Neurodegeneration with Brain Iron Accumulation (NBIA): an Update on Clinical Presentations, Histological and Genetic Underpinnings, and Treatment Considerations |
000F70 (2012) |
Travis S. Tierney [États-Unis] ; Andres M. Lozano [Canada] | Surgical Treatment for Secondary Dystonia |
000F73 (2012) |
Adriaan D. Coumou [Pays-Bas] ; J. Marc C. Van Dijk [Pays-Bas] ; Jeroen J. De Vries [Pays-Bas] ; Klaus L. Leenders [Pays-Bas] ; Jos M. A. Kuijlen [Pays-Bas] | Successful Surgical Treatment of an Arachnoid Cyst Inducing a Holmes' Tremor |
000F88 (2012) |
M. Konno ; T. Haseqawa ; T. Baba | Selective Serotonin Reuptake Inhibitors Emerge as the Therapeutic Agent for Synucleinopathies |
000F91 (2012) |
Robert Chinnapongse [États-Unis] ; Kristen Gullo [États-Unis] ; Paul Nemeth [États-Unis] ; YUXIN ZHANG [États-Unis] ; Lynn Griggs [États-Unis] | Safety and Efficacy of Botulinum Toxin Type B for Treatment of Sialorrhea in Parkinson's Disease: A Prospective Double-Blind Trial |
000F96 (2012) |
Raffaella Di Giacopo [Italie] ; Alfonso Fasano [Italie] ; Davide Quaranta [Italie] ; Giacomo Della Marca [Italie] ; Francesco Bove [Italie] ; Anna Rita Bentivoglio [Italie] | Rivastigmine as Alternative Treatment for Refractory REM Behavior Disorder in Parkinson's Disease |
001015 (2012) |
Stewart A. Factor [États-Unis] | Propranolol Therapy for Tardive Dyskinesia Revisited |
001029 (2012) |
Charles S. Venuto [États-Unis] ; Andrew Mcgarry [États-Unis] ; QING MA [États-Unis] ; Karl Kieburtz [États-Unis] | Pharmacologic Approaches to the Treatment of Huntington's Disease |
001064 (2012) |
Joseph H. Friedman [États-Unis] | Melperone Is Ineffective in Treating Parkinson's Disease Psychosis |
001065 (2012) |
Tetsutaro Ozawa [Japon] ; Kanako Sekiya [Japon] ; Yumi Sekine [Japon] ; Takayoshi Shimohata [Japon] ; Masahiko Tomita [Japon] ; Hideaki Nakayama [Japon] ; Naotaka Aizawa [Japon] ; Ryoko Takeuchi [Japon] ; Takayoshi Tokurake [Japon] ; Shinichi Katada [Japon] ; Masatoyo Nishizawa [Japon] | Maintaining Glottic Opening in Multiple System Atrophy: Efficacy of Serotonergic Therapy |
001067 (2012) |
Maria C. Rodriguez-Oroz [Espagne] ; Elena Moro [Canada] ; Paul Krack [France] | Long-Term Outcomes of Surgical Therapies for Parkinson's Disease |
001154 (2012) |
Thomas C. Edwards [Royaume-Uni] ; Ludvic Zrinzo [Royaume-Uni] ; Patricia Limousin [Royaume-Uni] ; Tom Foltynie [Royaume-Uni] | Deep Brain Stimulation in the Treatment of Chorea |
001157 (2012) |
Donald L. Bliwise [États-Unis] ; Lynn Marie Trotti [États-Unis] ; Anthony G. Wilson [États-Unis] ; Sophia A. Greer [États-Unis] ; Cathy Wood-Siverio [États-Unis] ; Jorge J. Juncos [États-Unis] ; Stewart A. Factor [États-Unis] ; Alan Freeman [États-Unis] ; David B. Rye [États-Unis] | Daytime Alertness in Parkinson's Disease: Potentially Dose-Dependent, Divergent Effects by Drug Class |
001161 (2012) |
Scott Y. H. Kim [États-Unis] ; Renee M. Wilson [États-Unis] ; H. Myra Kim [États-Unis] ; Robert G. Holloway [États-Unis] ; Raymond G. De Vries [États-Unis] ; Samuel A. Frank [États-Unis] ; Karl Kieburtz [États-Unis] | Comparison of Enrollees and Decliners of Parkinson Disease Sham Surgery Trials |
001227 (2012) |
Fabrizio Stocchi [Italie] ; Rupam Borgohain [Inde] ; Marco Onofrj [Italie] ; Anthony H. V. Schapira [Royaume-Uni] ; Mohit Bhatt [Inde] ; Valentina Lucini [Italie] ; Rodolfo Giuliani [Italie] ; Ravi Anand [Suisse] | A Randomized, Double-Blind, Placebo-Controlled Trial of Safinamide as Add-on Therapy in Early Parkinson's Disease Patients |
001234 (2012) |
Roger Kurlan [États-Unis] ; Giovanna Crespi [États-Unis] ; Barbara Coffey [États-Unis] ; Kirsten Mueller-Vahl [Allemagne] ; Stephen Koval [États-Unis] ; Glen Wunderlich [Canada] | A Multicenter Randomized Placebo-Controlled Clinical Trial of Pramipexole for Tourette's Syndrome |
001278 (2011) |
Christopher G. Goetz [États-Unis] ; Glenn T. Stebbins [États-Unis] ; Bichun Ouyang [États-Unis] | Visual plus nonvisual hallucinations in Parkinson's disease: Development and evolution over 10 years |
001300 (2011) |
Elina Tripoliti [Royaume-Uni] ; Laura Strong [Royaume-Uni] ; Freya Hickey [Royaume-Uni] ; Tom Foltynie [Royaume-Uni] ; Ludvic Zrinzo [Royaume-Uni] ; Joseph Candelario [Royaume-Uni] ; Marwan Hariz [Royaume-Uni] ; Patricia Limousin [Royaume-Uni] | Treatment of dysarthria following subthalamic nucleus deep brain stimulation for Parkinson's disease |
001301 (2011) |
Francisco Grandas [Espagne] ; Carlos Fernandez-Carballal [Espagne] ; Juan Guzman-De-Villoria [Espagne] ; Israel Ampuero [Espagne] | Treatment of a dystonic storm with pallidal stimulation in a patient with PANK2 mutation |
001303 (2011) |
David H. Benninger [États-Unis, Suisse] ; Mikhail Lomarev [États-Unis, Russie] ; Grisel Lopez [États-Unis] ; Natassja Pal [États-Unis] ; David A. Luckenbaugh [États-Unis] ; Mark Hallett [États-Unis] | Transcranial direct current stimulation for the treatment of focal hand dystonia |
001313 (2011) |
Vibeke Guldbrand Rasmussen [Danemark] ; Karen Stergaard [Danemark] ; Erik Dupont [Danemark] ; Steen Hvitfeldt Poulsen [Danemark] | The risk of valvular regurgitation in patients with Parkinson's disease treated with dopamine receptor agonists |
001331 (2011) |
Hasmet A. Hanagasi [Turquie] ; Hakan Gurvit [Turquie] ; P Nar Unsalan [Turquie] ; Hilal Horozoglu [Turquie] ; Nese Tuncer [Turquie] ; Aynur Feyzioglu [Turquie] ; Dilek Ince Gunal [Turquie] ; Gorsev G. Yener [Turquie] ; Raif Cakmur [Turquie] ; Huseyin A. Sahin [Turquie] ; Murat Emre [Turquie] | The effects of rasagiline on cognitive deficits in Parkinson's disease patients without dementia: A randomized, double‐blind, placebo‐controlled, multicenter study |
001332 (2011) |
Sean S. O'Sullivan [Royaume-Uni] ; Mary Johnson [Royaume-Uni] ; David R. Williams [Australie] ; Tamas Revesz [Royaume-Uni] ; Janice L. Holton [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Elaine K. Perry [Royaume-Uni] | The effect of drug treatment on neurogenesis in Parkinson's disease |
001350 (2011) |
Klaus Seppi [Autriche, Portugal] ; Daniel Weintraub [États-Unis] ; Miguel Coelho [Portugal] ; Santiago Perez-Lloret [France] ; Susan H. Fox [Canada] ; Regina Katzenschlager [Autriche] ; Eva-Maria Hametner [Autriche] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Christopher G. Goetz [États-Unis] ; Cristina Sampaio [Portugal] | The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the non‐motor symptoms of Parkinson's disease |
001351 (2011) |
Susan H. Fox [Canada] ; Regina Katzenschlager [Autriche] ; Shen-Yang Lim [Malaisie] ; Bernard Ravina [États-Unis] ; Klaus Seppi [Autriche] ; Miguel Coelho [Portugal] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Christopher G. Goetz [États-Unis] ; Cristina Sampaio [Portugal] | The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease |
001383 (2011) |
Carl E. Clarke [Royaume-Uni] ; Smitaa Patel [Royaume-Uni] ; Natalie Ives [Royaume-Uni] ; Caroline Rick [Royaume-Uni] ; Keith Wheatley [Royaume-Uni] ; Richard Gray [Royaume-Uni] | Should treatment for Parkinson's disease start immediately on diagnosis or delayed until functional disability develops? |
001393 (2011) |
Francisco J. Palomar [Espagne] ; Francisco Díaz-Corrales [Espagne] ; Fatima Carrillo [Espagne] ; Miguel Fernández-Del-Olmo [Espagne] ; Giacomo Koch [Italie] ; Pablo Mir [Espagne] | Sensory perception changes induced by transcranial magnetic stimulation over the primary somatosensory cortex in Parkinson's disease |
001403 (2011) |
Alfonso Fasano [Italie] ; Alessandro Di Matteo [Italie] ; Carmine Vitale [Italie] ; Giovanna Squintani [Italie] ; Laura Ferigo [Italie] ; Federica Bombieri [Italie] ; Gabriella Santangelo [Italie] ; Marianna Amboni [Italie] ; Paolo Barone [Italie] ; Michele Tinazzi [Italie] | Reversible Pisa syndrome in patients with Parkinson's disease on rasagiline therapy |
001443 (2011) |
Marina Svetel [Serbie] ; Tatjana Pekmezovi [Serbie] ; Aleksandra Tomi [Serbie] ; Nikola Kresojevi [Serbie] ; Aleksandra Potrebi [Serbie] ; Rada Ješi [Serbie] ; Vladimir S. Kosti [Serbie] | Quality of life in patients with treated and clinically stable Wilson's disease |
001459 (2011) |
Connie Marras [Canada] ; Michael P. Mcdermott [États-Unis] ; Ken Marek [États-Unis] ; Paula Rochon [Canada] ; Gary Naglie [Canada] ; Caroline M. Tanner [États-Unis] ; Alice Rudolph [États-Unis] ; Ira Shoulson [États-Unis] ; Anthony E. Lang [Canada] | Predictors of time to requiring dopaminergic treatment in 2 Parkinson's disease cohorts |
001498 (2011) |
Fabrizio Stocchi [Italie] ; Luigi Giorgi [Royaume-Uni] ; Brian Hunter [Royaume-Uni] ; Anthony Hv Schapira [Royaume-Uni] | PREPARED: Comparison of prolonged and immediate release ropinirole in advanced Parkinson's disease |
001550 (2011) |
Rodger Elble [États-Unis, Allemagne] ; Günther Deuschl [Allemagne] | Milestones in tremor research |
001557 (2011) |
Laurie J. Ozelius [États-Unis] ; Naomi Lubarr [États-Unis] ; Susan B. Bressman [États-Unis] | Milestones in dystonia |
001562 (2011) |
Olivier Rascol [France] ; Andres Lozano [Canada] ; Matthew Stern [États-Unis] ; Werner Poewe [Autriche] | Milestones in Parkinson's disease therapeutics |
001564 (2011) |
Ira Shoulson [États-Unis] ; Anne B. Young [États-Unis] | Milestones in Huntington disease |
001579 (2011) |
Elisa Garbayo [Espagne] ; Eduardo Ansorena [Espagne] ; Jose Luis Lanciego [Espagne] ; María Jose Blanco-Prieto [Espagne] ; María S. Aymerich [Espagne] | Long‐term neuroprotection and neurorestoration by glial cell‐derived neurotrophic factor microspheres for the treatment of Parkinson's disease |
001581 (2011) |
Codrin Lungu [États-Unis] ; Barbara I. Karp [États-Unis] ; Katharine Alter [États-Unis] ; Regina Zolbrod [États-Unis] ; Mark Hallett [États-Unis] | Long‐term follow‐up of botulinum toxin therapy for focal hand dystonia: Outcome at 10 years or more |
001582 (2011) |
Mathias Toft [Norvège] ; B Rd Lilleeng [Norvège] ; Jon Ramm-Pettersen [Norvège] ; Inger Marie Skogseid [Norvège] ; Vidar Gundersen [Norvège] ; Remo Gerdts [Norvège] ; Lena Pedersen [Norvège] ; Mona Skjelland [Norvège] ; Geir Ketil R Ste [Norvège] ; Espen Dietrichs [Norvège] | Long‐term efficacy and mortality in Parkinson's disease patients treated with subthalamic stimulation |
001583 (2011) |
René Reese [Allemagne] ; Doreen Gruber [Allemagne] ; Thomas Schoenecker [Allemagne] ; Hansjörg B Zner [Allemagne] ; Christian Blahak [Allemagne] ; H. Holger Capelle [Allemagne] ; Daniela Falk [Allemagne] ; Jan Herzog [Allemagne] ; Marcus O. Pinsker [Allemagne] ; Gerd H. Schneider [Allemagne] ; Christoph Schrader [Allemagne] ; Günther Deuschl [Allemagne] ; Günther M. Mehdorn [Allemagne] ; Andreas Kupsch [Allemagne] ; Jens Volkmann [Allemagne] ; Joachim K. Krauss [Allemagne] | Long‐term clinical outcome in meige syndrome treated with internal pallidum deep brain stimulation |
001589 (2011) |
Jasper E. Visser [Pays-Bas] ; David J. Schretlen [États-Unis] ; Bastiaan R. Bloem [Pays-Bas] ; Hyder A. Jinnah [États-Unis] | Levodopa is not a useful treatment for Lesch‐Nyhan disease |
001595 (2011) |
Alexandre Gironell [Espagne] ; Javier Pagonabarraga [Espagne] ; Berta Pascual-Sedano [Espagne] ; Jaime Kulisevsky [Espagne] | Lacosamide, another therapeutic failure in essential tremor: An open‐label trial |
001605 (2011) |
Giovanna Zorzi [Italie] ; Federica Zibordi [Italie] ; Luisa Chiapparini [Italie] ; Enrico Bertini [Italie] ; Lidia Russo [Italie] ; Antonio Piga [Italie] ; Filomena Longo [Italie] ; Barbara Garavaglia [Italie] ; Domenico Aquino [Italie] ; Mario Savoiardo [Italie] ; Alessandra Solari [Italie] ; Nardo Nardocci [Italie] | Iron‐related MRI images in patients with pantothenate kinase–associated neurodegeneration (PKAN) treated with deferiprone: Results of a phase II pilot trial |
001609 (2011) |
Nick H. G. Holford [Nouvelle-Zélande] ; John G. Nutt [États-Unis] | Interpreting the results of Parkinson's disease clinical trials: Time for a change |
001655 (2011) |
Stefan J. Groiss [Allemagne, Japon] ; Mario Siebler [Allemagne] ; Alfons Schnitzler [Allemagne] | Full recovery of adult onset opsoclonus myoclonus syndrome after early immunotherapy: A case report |
001682 (2011) |
Joseph Jankovic [États-Unis] ; Cynthia Comella [États-Unis] ; Angelika Hanschmann [Allemagne] ; Susanne Grafe [Allemagne] | Efficacy and safety of incobotulinumtoxinA (NT 201, Xeomin) in the treatment of blepharospasm—A randomized trial |
001708 (2011) |
José Fidel Baizabal Carvallo [États-Unis] ; Richard Simpson [États-Unis] ; Joseph Jankovic [États-Unis] | Diagnosis and treatment of complications related to deep brain stimulation hardware |
001710 (2011) |
Robert A. Hauser [États-Unis] ; Peggy Auinger [États-Unis] | Determination of minimal clinically important change in early and advanced Parkinson's disease |
001711 (2011) |
Ping-Lei Pan [République populaire de Chine] ; He-Han Tang [République populaire de Chine] ; Qin Chen [République populaire de Chine] ; Wei Song [République populaire de Chine] ; Hui-Fang Shang [République populaire de Chine] | Desferrioxamine treatment of aceruloplasminemia: Long‐term follow‐up |